These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6687615)
1. Effect of aging on 6-keto-PGF1 alpha levels in normotensive and essential hypertensive males. Gotoh S; Ogihara T; Nakamaru M; Masuo K; Hata T; Kumahara Y Jpn Circ J; 1983 Mar; 47(3):309-12. PubMed ID: 6687615 [TBL] [Abstract][Full Text] [Related]
2. Levels of plasma 6-keto-PGF1 alpha in normotensive and essential hypertensive males with and without a family history of hypertension. Gotoh S; Ogihara T; Nakamaru M; Masuo K; Hata T; Kumahara Y Prostaglandins Leukot Med; 1983 Jan; 10(1):27-32. PubMed ID: 6572404 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension. Uehara Y; Ishii M; Ikeda T; Atarashi K; Takeda T; Murao S Prostaglandins Leukot Med; 1983 Apr; 10(4):455-64. PubMed ID: 6344103 [TBL] [Abstract][Full Text] [Related]
4. Plasma levels of 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension. Uehara Y; Ishii M; Ikeda T; Atarashi K; Takeda T; Murao S Prostaglandins Leukot Med; 1983 May; 11(1):95-104. PubMed ID: 6348803 [TBL] [Abstract][Full Text] [Related]
5. Effects of norepinephrine infusion on systemic hemodynamics and plasma 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension. Ishii M; Uehara Y; Hirata Y; Atarashi K; Ikeda T; Sugimoto T; Takeda T; Murao S Jpn Circ J; 1982 May; 46(5):494-502. PubMed ID: 7043017 [TBL] [Abstract][Full Text] [Related]
6. The effect of age on circulating 6-keto-prostaglandin F1 alpha in humans. Ylikorkala O; Osterman T; Lindén IB; Viinikka L Prostaglandins Leukot Med; 1982 Nov; 9(5):569-75. PubMed ID: 6960379 [TBL] [Abstract][Full Text] [Related]
7. [Levels of plasma 6-keto-PGF1 alpha in normotensive and essential hypertensive males with and without a family history of hypertension and effects of aging]. Gotoh S; Ogihara T; Nakamaru M; Hata T; Kumahara Y Nihon Naibunpi Gakkai Zasshi; 1982 Oct; 58(10):1341-9. PubMed ID: 6897890 [No Abstract] [Full Text] [Related]
8. Very low levels of 6-keto-prostaglandin F1 alpha in human plasma. Siess W; Dray F J Lab Clin Med; 1982 Mar; 99(3):388-98. PubMed ID: 7035588 [TBL] [Abstract][Full Text] [Related]
9. Measurement of 6-keto-prostaglandin E1 alpha in human plasma with radioimmunoassay: effect of prostacyclin infusion. Ylikorkala D; Viinikka L Prostaglandins Med; 1981 Apr; 6(4):427-36. PubMed ID: 7025068 [TBL] [Abstract][Full Text] [Related]
10. Increased plasma immunoreactive 6-keto-prostaglandin F1 alpha levels in newborns with idiopathic respiratory distress syndrome. Kääpä P; Koivisto M; Viinikka L; Ylikorkala O Pediatr Res; 1982 Oct; 16(10):827-9. PubMed ID: 6897290 [TBL] [Abstract][Full Text] [Related]
11. Plasma and amniotic fluid prostacyclin and thromboxane in mild pregnancy-induced hypertension. Brown HL; Klein L; Waitzman M Am J Perinatol; 1987 Apr; 4(2):152-4. PubMed ID: 3566883 [TBL] [Abstract][Full Text] [Related]
12. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2. Ylikorkala O; Mäkilä UM; Viinikka L Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904 [TBL] [Abstract][Full Text] [Related]
13. Prostacyclin in (extracted) plasma of essential hypertensives. Sundar S Acta Cardiol; 1987; 42(2):135-9. PubMed ID: 3300116 [TBL] [Abstract][Full Text] [Related]
14. Effects of phospholipases A2 from Vipera russelli snake venom on blood pressure, plasma prostacyclin level and renin activity in rats. Huang HC Toxicon; 1984; 22(2):253-64. PubMed ID: 6374970 [TBL] [Abstract][Full Text] [Related]
15. Effects of prostacyclin infusion on blood pressure and plasma renin activity in patients with essential hypertension. Kato T; Yoneda S; Koketsu M; Fujinami T Angiology; 1992 Feb; 43(2):110-20. PubMed ID: 1536471 [TBL] [Abstract][Full Text] [Related]
16. Release of prostaglandins by the mesenteric artery of the renovascular and spontaneously hypertensive rat. Desjardins-Giasson S; Gutkowska J; Garcia R; Genest J Can J Physiol Pharmacol; 1984 Jan; 62(1):89-93. PubMed ID: 6546893 [TBL] [Abstract][Full Text] [Related]
17. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats. Cao H; Wu Z; Zhou J; Chen Z; Kuang Y Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330 [TBL] [Abstract][Full Text] [Related]
18. Diminished urinary prostacyclin metabolite in essential hypertension. Grose JH; Lebel M; Gbeassor FM Clin Sci (Lond); 1980 Dec; 59 Suppl 6():121s-123s. PubMed ID: 7004719 [TBL] [Abstract][Full Text] [Related]
19. Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism. Rodríguez-García JL; Villa E; Serrano M; Gallardo J; García-Robles R Blood Press; 1999; 8(5-6):279-84. PubMed ID: 10803488 [TBL] [Abstract][Full Text] [Related]
20. [A study of the role of plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha in epidemic hemorrhagic fever]. Wang GQ; Zou ZZ; Yu DP Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):138-40, 188. PubMed ID: 1976492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]